Triple

T19157493
Position Surface form Disambiguated ID Type / Status
Subject Singulair E468961 entity
Predicate metabolizingEnzyme P37221 FINISHED
Object CYP2C9 NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CYP2C9 | Statement: [Singulair, metabolizingEnzyme, CYP2C9]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: CYP2C9
Context triple: [Singulair, metabolizingEnzyme, CYP2C9]
  • A. CYP2C9 chosen
    CYP2C9 is a liver enzyme of the cytochrome P450 family that plays a key role in metabolizing various drugs, including many nonsteroidal anti-inflammatory agents and anticoagulants.
  • B. CYP2C19
    CYP2C19 is a liver enzyme of the cytochrome P450 family that plays a key role in the metabolism of various drugs, including certain antidepressants, proton pump inhibitors, and antiplatelet agents.
  • C. CYP2B6
    CYP2B6 is a human liver cytochrome P450 enzyme that plays a key role in the metabolism of various drugs and xenobiotics.
  • D. CYP2D6
    CYP2D6 is a highly polymorphic cytochrome P450 enzyme that plays a major role in the metabolism of many drugs, contributing significantly to interindividual variability in drug response.
  • E. CYP3A5
    CYP3A5 is a liver-expressed cytochrome P450 enzyme that metabolizes various drugs and xenobiotics, contributing to interindividual variability in drug clearance.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d8dd084ff48190ac0f8c46ee722629 completed April 10, 2026, 11:20 a.m.
NER Named-entity recognition batch_69e5eeba91a081909c04d61d6117da06 completed April 20, 2026, 9:15 a.m.
Created at: April 10, 2026, 12:06 p.m.